Chung S Yang Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

1/2018	Anti-inflammatory effects of newly synthesized α-galacto-oligosaccharides on dextran sulfate sodium-induced colitis in C57BL/6J mice.
11/2017	β-Sitosterol and stigmasterol ameliorate dextran sulfate sodium-induced colitis in mice fed a high fat Western-style diet.
10/2012	Time-selective chemoprevention of vitamin E and selenium on esophageal carcinogenesis in rats: the possible role of nuclear factor kappaB signaling pathway.
2/2011	Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate.
8/2008	Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer.
11/2006	Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention.
9/2006	Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors.
3/2005	Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.
12/2002	Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chung S Yang Research Topics

Disease

144	Neoplasms (Cancer) 01/2022 - 01/2002
84	Carcinogenesis 01/2022 - 01/2002
24	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2002
23	Inflammation (Inflammations) 01/2021 - 12/2002
20	Adenocarcinoma 01/2022 - 01/2002
17	Body Weight (Weight, Body) 01/2022 - 01/2004
17	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2002
17	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2007
15	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2005
14	Lung Neoplasms (Lung Cancer) 01/2018 - 10/2006
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2009 - 01/2002
9	Colitis 01/2021 - 06/2002
9	Esophageal Squamous Cell Carcinoma 06/2014 - 09/2003
9	Adenoma (Adenomas) 10/2012 - 01/2004
8	Hyperplasia 01/2019 - 08/2002
7	Aberrant Crypt Foci 01/2021 - 01/2003
6	Stomach Neoplasms (Stomach Cancer) 01/2020 - 09/2002
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2019 - 09/2008
6	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 09/2002
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2009
5	Fatty Liver 06/2019 - 09/2008
5	Chronic Disease (Chronic Diseases) 03/2018 - 11/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 11/2005
4	Insulin Resistance 05/2019 - 09/2008
4	Obesity 02/2017 - 09/2008
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2015 - 10/2013
4	Metaplasia 07/2009 - 06/2004
4	Mouth Neoplasms (Oral Cancer) 07/2008 - 01/2004
4	Skin Neoplasms (Skin Cancer) 01/2008 - 09/2002
3	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2018

Drug/Important Bio-Agent (IBA)

82	TeaIBA 08/2021 - 01/2002
43	PolyphenolsIBA 08/2021 - 01/2002
32	Tocopherols (Tocopherol)IBA 01/2022 - 01/2007
20	Vitamin E FDA LinkGeneric 01/2022 - 09/2003
16	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2002
14	CarcinogensIBA 01/2019 - 06/2004
12	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2017 - 09/2002
11	AzoxymethaneIBA 01/2019 - 01/2003
11	Caffeine (No Doz)FDA LinkGeneric 01/2012 - 09/2002
11	Arachidonic Acid (Vitamin F)IBA 11/2008 - 12/2002
10	CateninsIBA 01/2021 - 02/2011
10	Dextran SulfateIBA 01/2021 - 06/2002
10	AntioxidantsIBA 03/2018 - 01/2002
9	polyphenon EIBA 01/2021 - 12/2006
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2002
9	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018 - 12/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2003
9	Catechin (Z 7300)IBA 12/2016 - 04/2003
8	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2021 - 02/2011
8	CholesterolIBA 10/2018 - 09/2003
8	Biological ProductsIBA 12/2017 - 01/2004
8	Caspase 3 (Caspase-3)IBA 01/2015 - 01/2007
8	Celecoxib (Celebrex)FDA Link 03/2014 - 10/2004
7	benzocycloheptapyridineIBA 01/2021 - 02/2011
7	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2012
7	SeleniumIBA 11/2019 - 09/2003
7	Estrogens (Estrogen)FDA Link 01/2018 - 06/2009
7	3-nitrotyrosineIBA 01/2017 - 08/2008
7	CurcuminIBA 10/2013 - 08/2002
7	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2012 - 01/2003
7	Dinoprostone (PGE2)FDA Link 10/2012 - 12/2002
7	Atorvastatin (Lipitor)FDA Link 08/2012 - 05/2008
6	TocotrienolsIBA 01/2022 - 04/2010
6	LipidsIBA 01/2022 - 12/2006
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 11/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2007
5	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 01/2005
5	Drinking WaterIBA 01/2018 - 02/2009
5	EnzymesIBA 12/2016 - 11/2006
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2015 - 01/2008
5	Leukotriene B4IBA 10/2012 - 01/2003
5	gamma-TocopherolIBA 04/2010 - 09/2003
5	IronIBA 07/2009 - 06/2002
4	NF-kappa B (NF-kB)IBA 01/2021 - 10/2003
4	gallocatechol (epigallocatechin)IBA 01/2019 - 09/2005
4	8-Hydroxy-2'-DeoxyguanosineIBA 01/2018 - 05/2010
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2017 - 09/2004
4	Conditioned Culture MediaIBA 01/2017 - 02/2012
4	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2015 - 01/2004
4	MethyltransferasesIBA 01/2015 - 11/2003
4	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 11/2012 - 01/2005
4	alpha-Tocopherol FDA Link 04/2010 - 09/2003
4	beta CateninIBA 11/2008 - 11/2005
4	anthraceneIBA 07/2008 - 08/2002
3	CopperIBA 09/2021 - 01/2015
3	Cadherins (E-Cadherin)IBA 01/2019 - 11/2005
3	Monomeric GTP-Binding ProteinsIBA 01/2019 - 05/2008
3	StigmasterolIBA 10/2018 - 11/2017
3	Triglycerides (Triacylglycerol)IBA 10/2018 - 11/2011
3	gamma-sitosterol (beta-sitosterol)IBA 10/2018 - 11/2017
3	nitrosobenzylmethylamineIBA 01/2018 - 03/2011
3	CytokinesIBA 01/2018 - 11/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 10/2003
3	Dextrans (Dextran)FDA Link 01/2017 - 02/2011
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 02/2011

Therapy/Procedure

20	Chemoprevention 01/2021 - 02/2003
9	Therapeutics 01/2017 - 04/2004
4	Intraperitoneal Injections 02/2012 - 04/2005
3	Drug Therapy (Chemotherapy) 11/2019 - 07/2008
3	Aftercare (After-Treatment) 01/2018 - 08/2005